CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Nonredeemable Noncontrolling Interests
Balance at beginning of period at Jan. 28, 2017	$ 980,994	$ 841	$ 480,435	$ 1,215,079	$ (161,389)	$ (565,744)	$ 11,772
Stock at beginning of period (in shares) at Jan. 28, 2017		84,069,492				56,440,482
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)	(3,901)			(7,894)			3,993
Other comprehensive income (loss)	71,775				69,537		2,238
Issuance of common stock under stock compensation plans including tax effect (in shares)		1,113,713
Issuance of common stock under stock compensation plans including tax effect	(1,257)	$ 10	(1,267)
Issuance of stock under Employee Stock Purchase Plan (in shares)		54,300				(54,300)
Issuance of stock under Employee Stock Purchase Plan	566		17			$ 549
Share-based compensation	18,852		18,758	94
Dividends	(76,048)			(76,048)
Share repurchases (in shares)		(3,866,387)				3,866,387
Share repurchases	(56,159)	$ (38)	38			$ (56,159)
Noncontrolling interest capital contribution	11						11
Noncontrolling interest capital distribution	(1,358)						(1,358)
Balance at end of period at Feb. 03, 2018	933,475	$ 813	498,249	1,132,173	(93,062)	$ (621,354)	16,656
Stock at end of period (in shares) at Feb. 03, 2018		81,371,118				60,252,569
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)	17,166			14,099			3,067
Other comprehensive income (loss)	(33,353)				(33,117)		(236)
Issuance of common stock under stock compensation plans including tax effect (in shares)		1,083,613
Issuance of common stock under stock compensation plans including tax effect	5,006	$ 12	4,994
Issuance of stock under Employee Stock Purchase Plan (in shares)		43,737				(43,737)
Issuance of stock under Employee Stock Purchase Plan	738		283			$ 455
Share-based compensation	19,973		19,794	179
Dividends	(74,533)			(74,533)
Share repurchases (in shares)		(1,118,808)				1,118,808
Share repurchases	(17,587)	$ (11)	11			$ (17,587)
Noncontrolling interest capital distribution	(3,069)						(3,069)
Balance at end of period at Feb. 02, 2019	$ 853,645	$ 814	523,331	1,077,747	(126,179)	$ (638,486)	16,418
Stock at end of period (in shares) at Feb. 02, 2019	81,371,118	81,379,660				61,327,640
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)	$ 101,229			95,975			5,254
Other comprehensive income (loss)	(15,083)				(15,712)		629
Issuance of common stock under stock compensation plans including tax effect (in shares)		1,155,166				(994,519)
Issuance of common stock under stock compensation plans including tax effect	2,801	$ 10	(8,699)			$ 11,490
Issuance of stock under Employee Stock Purchase Plan (in shares)		53,424				(53,424)
Issuance of stock under Employee Stock Purchase Plan	783	$ 1	166			$ 616
Share-based compensation	24,290		24,079	211
Dividends	(41,840)			(41,840)
Share repurchases (in shares)		(16,739,740)				16,739,740
Share repurchases	(288,067)	$ (167)	167			$ (288,067)
Noncontrolling interest capital distribution	(668)						(668)
Equity component value of convertible note issuance, net	42,320		42,320
Sale of common stock warrant	28,080		28,080
Purchase of convertible note hedge	(46,440)		(46,440)
Balance at end of period at Feb. 01, 2020	$ 661,347	$ 658	$ 563,004	$ 1,130,409	$ (139,910)	$ (914,447)	$ 21,633
Stock at end of period (in shares) at Feb. 01, 2020	81,379,660	65,848,510				77,019,437